[Changes in the T-cell component in patients with subleukemic myelosis at various stages of the pathologic process].
T-cell immunity was assessed in 111 patients with subleukemic myelosis. In such patients with large tumor mass and leukemia exacerbation the amount of immunocompetent cells and their functional activity were reduced more prominently. Association of infection and inflammation promoted aggravation of initial immune deficiency.
Guseva
S A
SA
D000328:Adult; D000368:Aged; D005260:Female; D005667:Furunculosis / Q000150:complications / Q000276:immunology* / Q000473:pathology; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000150:complications / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000150:complications / Q000276:immunology* / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology*
Izmeneniia T-kletochnogo zvena immuniteta u bol'nykh subleĭkemicheskim mielozom na razlichnykh stadiiakh patologicheskogo protsessa.